Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Dacarbazine: Workflows for Cancer Drug Response
2026-08-20
Dacarbazine is an antineoplastic chemotherapy drug that can reveal both growth suppression and cell killing in cancer models. This practical guide turns that distinction into reproducible assay design, dose scheduling, and troubleshooting strategies for melanoma, lymphoma, and sarcoma research.
-
TRIM21–ERK1/2 Signaling in Pituitary Adenoma Resistance
2026-08-20
The reference study identifies TRIM21 as an oncogenic and drug-resistance factor in pituitary adenomas, linking its PRY-SPRY domain to K27-linked ERK1/2 ubiquitination, MEK interaction, and ERK phosphorylation. Its combination of CRISPR screening, biochemical validation, and drug screening nominates TRIM21 suppression— including with Quisinostat—as a strategy for studying resistant pituitary tumor models.
-
Tyrothricin: Designing Better Antimicrobial Assays
2026-08-19
Tyrothricin is a peptide antibiotic mixture best understood as a mechanistic perturbation tool, not merely a broad-spectrum antimicrobial. This guide connects membrane-focused assay design with host-cell signaling controls and practical workflow decisions.
-
Cholesterol Hinders LNP Intracellular Trafficking
2026-08-19
The 2025 reference study introduced a streptavidin–biotin-DNA tracking platform with high-throughput imaging to resolve how lipid nanoparticle composition shapes intracellular trafficking. Its central finding is that increasing cholesterol promotes aggregation of LNP-containing peripheral early endosomes, restricting progression through the endolysosomal pathway and reducing access to compartments associated with cargo release.
-
PNU 74654: Reading Wnt Perturbation Correctly
2026-08-18
PNU 74654 is a Wnt signaling pathway inhibitor best evaluated through pathway-aware, context-specific assays. This article connects its research use to the WNT5a/GSK3/β-catenin findings in muscle progenitors while clarifying experimental design, controls, and interpretation limits.
-
Medroxyprogesterone Acetate: A Metabolic Assay Lens
2026-08-18
Medroxyprogesterone acetate is more than a progesterone-receptor agonist: it can serve as a controlled trigger for studying how hormone signaling is translated into endometrial lipid metabolism. This evidence-driven guide connects MPA assay design with ACSL4-dependent fatty acid oxidation while clarifying implications for renal, reproductive, and neurobiological research.
-
CNQX for Reproducible Excitotoxicity Assays
2026-08-17
This scenario-driven guide explains how CNQX supports mechanistic interpretation in neuronal viability, proliferation, and cytotoxicity workflows. It connects receptor pharmacology, solution preparation, data interpretation, and vendor selection to the documented specifications of CNQX SKU B6222.
-
BMAL1 Phase Separation in Circadian Transcription
2026-08-17
The reference study identifies BMAL1 as a phase-separating transcriptional regulator that forms dynamic nuclear condensates and organizes CLOCK, p300, and MED1 at E-box DNA. Its deletion and rescue experiments connect an N-terminal intrinsically disordered region to rhythmic transcription and locomotor behavior, offering a mechanistic explanation for why transcription-factor occupancy alone does not fully predict circadian output.
-
Methylation Control with 3-Deazaadenosine
2026-08-16
A translational perspective on how 3-Deazaadenosine, an S-adenosylhomocysteine hydrolase inhibitor, can connect methylation biology, m6A research, and preclinical antiviral studies without overstating the evidence.
-
DHJS, Acacetin, and Pyroptosis in Disc Degeneration
2026-08-15
A 2025 Phytomedicine study identifies an acacetin-mediated MAPK1/HMOX1 pathway through which Duhuo Jisheng decoction may protect nucleus pulposus cells from pyroptosis during intervertebral disc degeneration. By connecting mitochondrial quality control with inflammatory cell death, the work provides a mechanistic framework for evaluating traditional medicine-derived interventions in experimental disc disease.
-
PSPro Maps Spatial Proteomes at Single-Cell Resolution
2026-08-14
Mao and colleagues introduce PSPro, a proximity-labeling workflow that captures cell-type-associated proteomes directly from complex tissue slices while retaining spatial context. The study shows how optimized antibody-targeted biotinylation, affinity purification, and optional laser microdissection can reveal proteomic heterogeneity among tumor and immune cell populations.
-
One-step TUNEL Cy5 Apoptosis Detection Kit Workflow
2026-08-14
Translate DNA fragmentation into spatially resolved imaging or quantitative flow-cytometry data with a practical Cy5 workflow for cells and tissue. The assay is especially useful for testing apoptosis-related mechanisms in glucocorticoid-induced osteonecrosis models while preserving flexibility for broader programmed cell death research.
-
Protease Inhibitor Cocktail for OXPHOS Assays
2026-08-13
Protect labile OXPHOS, cancer-metabolism, and signaling proteins from extraction-associated degradation with an EDTA-free, DMSO-based inhibitor system. This practical guide connects sample-preservation choices to LRPPRC–dasatinib studies, Western blotting, Co-IP, pull-down, kinase, and tissue-extract workflows.
-
Carvedilol Phosphate in Hepatic IRI Research
2026-08-13
Carvedilol Phosphate provides a controllable beta-adrenergic signaling probe for connecting cardiovascular pharmacology research with hepatocyte–macrophage biology. This guide translates the Arrb2–6-ketoLCA findings into practical in vitro and in vivo assay workflows, with formulation, dosing, controls, and troubleshooting guidance.
-
Thiothixene Drives Continual Macrophage Efferocytosis
2026-08-12
A 2025 Science Signaling study identifies Thiothixene as a compound that enhances macrophage clearance of apoptotic and lipid-laden cells. Its effects involve Stra6L, vitamin A signaling, and Arginase 1, while dopamine inhibits efferocytosis and is only partly counteracted by Thiothixene.